EICHOR
● Recruiting
A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)
Condition: Short Bowel Syndrome (SBS) · SBS Associated With Intestinal Failure (SBS-IF) · Sponsor: VectivBio AG
About this study
This Phase 3 placebo-controlled study is planned to further investigate the efficacy, safety, and tolerability of apraglutide in the overall SBS-IF (short bowel syndrome associated with intestinal failure) population during 24 weeks of study treatment. It is expected that approximately 124 participants will be randomized worldwide to either apraglutide or placebo in a 1:1 ratio in this trial.
This description comes directly from the study's public registry record.
Talk to the study team
Emie Liu, MD · +41 61 551 30 30 · clinicaltrialenquiries@ironwoodpharma.com
Always discuss trial participation with your own doctor first.
Locations (94)
| Ronald Reagan UCLA Medical Center, Center for the Health Sciences | Los Angeles, California, United States | Not Yet Recruiting |
| Denver Health Medical Center | Denver, Colorado, United States | Not Yet Recruiting |
| MedStar Georgetown University Hospital | Washington D.C., District of Columbia, United States | Not Yet Recruiting |
| University of Florida Health (UF Health) | Gainesville, Florida, United States | Not Yet Recruiting |
| GI Pros | Naples, Florida, United States | Recruiting |
| Cleveland Clinic Florida | Weston, Florida, United States | Not Yet Recruiting |
| Loyola University Medical Center | Maywood, Illinois, United States | Not Yet Recruiting |
| UofL Physicians - Colon & Rectal Surgery | Louisville, Kentucky, United States | Not Yet Recruiting |
| Henry Ford Medical Center - Columbus | Novi, Michigan, United States | Not Yet Recruiting |
| Albany Medical Center | Albany, New York, United States | Not Yet Recruiting |
| Mount Sinai Medical Center, RMTI - Intestinal Transplantation & Rehabilitation | New York, New York, United States | Not Yet Recruiting |
| Duke University Medical Center | Durham, North Carolina, United States | Not Yet Recruiting |
+ 82 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07742735